Health-related quality of life and functionality in primary caregiver of surviving pediatric COVID-19

Imagem de Miniatura
Arquivos
art_MARTINS_Healthrelated_quality_of_life_and_functionality_in_primary_2023.PDF (408.76 KB)
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
FRONTIERS MEDIA SA
Autores
Citação
FRONTIERS IN PUBLIC HEALTH, v.11, article ID 1117854, 9p, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
ObjectivesTo prospectively assess health-related quality of life (HRQoL), global functionality, and disability in primary caregivers of surviving children and adolescents after COVID-19. MethodsA longitudinal observational study was carried out on primary caregivers of surviving pediatric post-COVID-19 patients (n = 51) and subjects without COVID-19 (n = 60). EuroQol five-dimension five-level questionnaire (EQ-5D-5L) and 12-question WHO Disability Assessment Schedule 2.0 (WHODAS 2.0) were answered for both groups. The univariate regression analysis was carried out using SPSS (v 20) and significance was established at 5%. ResultsThe median duration between COVID-19 diagnosis in children and adolescents and longitudinal follow-up visits was 4.4 months (0.8-10.7). The median age of children and adolescents caregivers with laboratory-confirmed COVID-19 was similar to primary caregivers of subjects without laboratory-confirmed COVID-19 [43.2 (31.6-60.9) vs. 41.5 (21.6-54.8) years, p = 0.08], as well as similar female sex (p = 1.00), level of schooling (p = 0.11), social assistance program (p = 0.28), family income/month U$ (p = 0.25) and the number of household's members in the residence (p = 0.68). The frequency of slight to extreme problems (level & GE; 2) of the pain/discomfort domain according to EQ-5D-5L score was significantly higher in the former group [74% vs. 52.5%, p = 0.03, OR = 2.57 (1.14-5.96)]. The frequency of disability according to WHODAS 2.0 total score was similar to those without disability and unknown (p = 0.79); however, with a very high disability in both groups (72.5% and 78.3%). Further analysis of primary caregivers of children and adolescents with post-COVID-19 condition (PCC) [n = 12/51 (23%)] compared to those without PCC [n = 39/51(77%)] revealed no differences between demographic data, EQ-5D-5L and WHODAS 2.0 scores in both groups (p > 0.05). ConclusionWe longitudinally demonstrated that pain/discomfort were predominantly reported in approximately 75% of primary caregiver of COVID-19 patients, with high disability in approximately three-quarters of both caregiver groups. These data emphasized the prospective and systematic caregiver burden evaluation relevance of pediatric COVID-19.
Palavras-chave
pediatric, children, adolescent, COVID-19, caregiver burden, quality of life, chronic disease, public health
URI
https://observatorio.fm.usp.br/handle/OPI/54705
Referências
  1. Alveno RA, 2018, J PEDIAT-BRAZIL, V94, P539, DOI 10.1016/j.jped.2017.07.014
  2. Andrews G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008343
  3. Astley C, 2022, PHYSIOL REP, V10, DOI 10.14814/phy2.15201
  4. Battistella LR, 2022, BMJ OPEN, V12, DOI 10.1136/bmjopen-2021-057246
  5. Beavis KG, 2020, J CLIN VIROL, V129, DOI 10.1016/j.jcv.2020.104468
  6. Passone CGB, 2020, REV PAUL PEDIATR, V38, DOI 10.1590/1984-0462/2020/38/2018101
  7. CDC, 2022, POST COVID COND
  8. Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045
  9. Craig BM, 2017, QUAL LIFE RES, V26, P2489, DOI 10.1007/s11136-017-1591-8
  10. Darlington ASE, 2021, PEDIATR BLOOD CANCER, V68, DOI 10.1002/pbc.28790
  11. Marques HHD, 2021, CLINICS, V76, DOI 10.6061/clinics/2021/e3488
  12. Durso DF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083926
  13. Fink TT, 2021, CLINICS, V76, DOI 10.6061/clinics/2021/e3511
  14. Higgins V, 2021, CRIT REV CL LAB SCI, V58, P297, DOI 10.1080/10408363.2020.1860895
  15. Izquierdo-Pujol J, 2022, FRONT PEDIATR, V10, DOI 10.3389/fped.2022.894204
  16. Khoja O, 2022, J PAIN RES, V15, P1729, DOI 10.2147/JPR.S365026
  17. Kompaniyets L, 2022, MMWR-MORBID MORTAL W, V71, P993, DOI 10.15585/mmwr.mm7131a3
  18. Kozu KT, 2022, JCR-J CLIN RHEUMATOL, V28, pE506, DOI 10.1097/RHU.0000000000001782
  19. Leal GN, 2022, MICROCIRCULATION, V29, DOI 10.1111/micc.12750
  20. Leon-Campos Alvaro, 2023, Int J Environ Res Public Health, V20, DOI 10.3390/ijerph20065081
  21. Merzon E, 2022, INT J ENV RES PUB HE, V19, DOI 10.3390/ijerph19105993
  22. Mirhosseini S, 2022, HEALTH SCI REP-US, V5, DOI 10.1002/hsr2.942
  23. Orsini A, 2021, J PSYCHIATR RES, V135, P256, DOI 10.1016/j.jpsychires.2021.01.024
  24. Qamar MA, 2022, ANN MED SURG, V75, DOI 10.1016/j.amsu.2022.103361
  25. Ramos GF, 2019, J PEDIAT-BRAZIL, V95, P667, DOI 10.1016/j.jped.2018.06.006
  26. Roessler M, 2022, PLOS MED, V19, DOI 10.1371/journal.pmed.1004122
  27. Seessle J, 2022, CLIN INFECT DIS, V74, P1191, DOI 10.1093/cid/ciab611
  28. Shen B, 2020, AM J TRANSL RES, V12, P1348
  29. Silveira C, 2013, REV ASSOC MED BRAS, V59, P234, DOI 10.1016/j.ramb.2012.11.005
  30. Turner Jane, 2007, Palliat Support Care, V5, P135, DOI 10.1017/S1478951507070204
  31. World Health Organization, 2020, WHO COR DIS COVID 19
  32. World Health Organization, 2021, EXP OUR UND POST COV
  33. World Health Organization, 2023, CLIN CAS DEF POST CO, P1
  34. Zakaria SM, 2022, INT J ENV RES PUB HE, V19, DOI 10.3390/ijerph191912219
  35. Zimmermann P, 2022, BMJ-BRIT MED J, V376, DOI 10.1136/bmj.o143

Coleções
Artigos e Materiais de Revistas Científicas - FM/MLS
Artigos e Materiais de Revistas Científicas - COVID-19
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - FM/MPE
Artigos e Materiais de Revistas Científicas - FM/MPT
Artigos e Materiais de Revistas Científicas - HC/ICESP
Carregar mais